This is a page that curates AI-related papers published worldwide. All content here is summarized using Google Gemini and operated on a non-profit basis. Copyright for each paper belongs to the authors and their institutions; please make sure to credit the source when sharing.
ECG-SMART-NET: A Deep Learning Architecture for Precise ECG Diagnosis of Occlusion Myocardial Infarction
Created by
Haebom
Author
Nathan T. Riek, Murat Akcakaya, Zeineb Bouzid, Tanmay Gokhale, Stephanie Helman, Karina Kraevsky-Philips, Rui Qi Ji, Ervin Sejdic, Jessica K. Z egre-Hemsey, Christian Martin-Gill, Clifton W. Callaway, Samir Saba, Salah Al-Zaiti
Outline
This paper presents the development and evaluation of ECG-SMART-NET for the identification of occlusive myocardial infarction (OMI). OMI is a severe cardiac arrest characterized by complete occlusion of one or more coronary arteries, requiring immediate cardiac catheterization to restore blood flow to the heart. In 12-lead electrocardiograms (ECGs), two-thirds of OMI cases are visually difficult to identify and can be fatal if not identified quickly. In this study, we propose ECG-SMART-NET, a clinically relevant modification of the existing ResNet-18 architecture designed to capture temporal features and spatial correspondence or mismatch between leads. We compared our results with other state-of-the-art models using a multi-site real clinical dataset (10,393 ECGs, 7,397 patients, OMI incidence 7.2%) and found that ECG-SMART-NET outperformed other models in OMI classification, achieving a test AUC of 0.953 [0.921, 0.978].
Takeaways, Limitations
•
Takeaways:
◦
ECG-SMART-NET outperforms state-of-the-art random forest models in OMI prediction.
◦
We demonstrate that this architecture is more suitable for OMI identification than the existing ResNet-18 architecture.
◦
We present a novel CNN architecture that effectively learns temporal and spatial features.
◦
It can contribute to improving early diagnosis and treatment of OMI.
•
Limitations:
◦
Further consideration is needed regarding the size and diversity of the dataset used.
◦
Additional evaluation of generalization performance across diverse populations is needed.
◦
Further research and validation are needed for clinical application.
◦
Further research is needed on the interpretability of the model.